Qualifying for Spravato: The Checklist
SaveQualifying for Spravato comes down to assembling a record that fits the approved use: documented antidepressant trials that did not work, a clear treatment-resistant depression diagnosis, and a certified treatment center to deliver it. Aligning those three pieces with your prescriber meets the core criteria most plans require.
Last updated: July 2026
What does the qualification checklist actually include?
It helps to treat qualifying as gathering evidence rather than passing a gate. Three items carry most of the weight: a documented history of antidepressant treatment that did not provide enough relief, a diagnosis of treatment-resistant depression recorded in your chart, and access to a certified center that can administer the drug. Spravato's approved use is exactly this treatment-resistant population, which is why plans and clinics organize eligibility around those pieces 1Ref 1Agboola F et al. (2020).The Effectiveness and Value of Esketamine for the Management of Treatment-Resistant Depression.esketamine-cost-effectivenessesketamine-value-assessmenticer-reporttreatment-resistant-depression-cost. Working through them one at a time with your prescriber is more productive than waiting for a single yes-or-no verdict. Once the record fits, the question shifts from "do I qualify" to how coverage for Spravato applies to your plan, which is a more answerable one.
How do you document two antidepressant trials?
The trial history is usually the piece people overlook, and it is often the most decisive. Plans generally want a record showing that you tried antidepressant medications and that they did not produce an adequate response — the same kind of documented sequence that supports other advanced treatments. The comparative evidence base recognizes that reaching an adequate response frequently takes more than one medication, so this history is common rather than unusual 2Ref 2Cipriani A, Furukawa TA, Salanti G, et al. (2018).Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.antidepressant-efficacymedication-acceptabilitymedication-selection. What matters is that it is written down: which medications, roughly when, and that the response was insufficient. If those trials happened with a previous prescriber, requesting those records — the same trial history that governs TMS coverage — is often the single most useful step you can take before applying.
What diagnosis language do plans look for?
The wording in your chart carries real weight. Coverage is built for treatment-resistant depression, so the record works best when the diagnosis and the treatment-resistant framing are stated clearly rather than implied. This is not about gaming the system; it is about making sure the chart accurately reflects a situation that already fits the criteria. Your prescriber is the person who documents this, and it is reasonable to ask that the diagnosis and prior-treatment history be captured plainly so the plan can read them. Real-world data show that patients who do access esketamine typically do so through this documented, treatment-resistant pathway 3Ref 3Zhdanava M et al. (2023).Esketamine nasal spray for major depressive disorder with acute suicidal ideation or behavior: description of treatment access, utilization, and claims-based outcomes in the United States.esketamine-coveragespravato-accessclaims-based-utilizationinterventional-access. A record that names the condition clearly saves a round of back-and-forth later.
How do you find a certified treatment center?
Because Spravato is delivered only at approved sites, locating one is part of qualifying rather than an afterthought. The drug is administered under a federal safety program at certified centers, so your practical options are the certified clinics near you — ideally ones in your plan's network. Federal treatment locators such as FindTreatment.gov can help you identify mental-health facilities in your area to start that search 4Ref 4Substance Abuse and Mental Health Services Administration (SAMHSA) (2025).FindTreatment.gov.treatment-locatorfind-low-cost-caresliding-fee-clinicsfree-confidential-referral. When you contact a center, it is fair to ask whether it is certified for Spravato, whether it takes your insurance, and what its intake requires. Lining up the site early means that once your record qualifies, you are not left hunting for somewhere to actually receive treatment.
When your prescriber turns the checklist into an application
The pieces of the checklist come together in your prescriber's hands, because they hold the record and submit the request. Bringing them a clear picture — your medication history, your current treatment, and a certified center you can reach — lets them assemble an application that fits the criteria rather than one that invites questions. If you use Gale to connect with a provider, you can start that conversation with your history organized, which tends to shorten the path from "do I qualify" to a decision. And if any part of the checklist feels out of reach, that is worth naming directly with your care team, since they can often fill the gap or point you toward a program that helps. Once the record is ready, what a session costs becomes the next practical question.
Common questions
Related
Paying for Mental Health Care
Insurance Coverage for Spravato: Who QualifiesPaying for Mental Health Care
Why Spravato Only Happens at Certified CentersPaying for Mental Health Care
What Spravato Costs Per Session, Honestly
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
If things feel heavy, a person is available anytime — call or text 988.
If you're pursuing Spravato because things feel worse
- —Thoughts of suicide, or of not wanting to be alive
- —Depression deepening while you gather records and referrals
- —Feeling unable to keep up current care while you work the checklist
Spravato eligibility and center requirements vary by health plan and clinic; this article describes general patterns, not your specific policy or medical situation. It is general information, not medical or insurance advice. If you are in crisis, call or text 988 (Suicide & Crisis Lifeline), free and available 24/7.
References
- 1.Agboola F et al. (2020). The Effectiveness and Value of Esketamine for the Management of Treatment-Resistant Depression. Journal of Managed Care & Specialty Pharmacy (JMCP). doi:10.18553/jmcp.2020.26.1.16 ✓esketamine-cost-effectivenessesketamine-value-assessmenticer-reporttreatment-resistant-depression-cost
- 2.Cipriani A, Furukawa TA, Salanti G, et al. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet. doi:10.1016/S0140-6736(17)32802-7 ✓antidepressant-efficacymedication-acceptabilitymedication-selection
- 3.Zhdanava M et al. (2023). Esketamine nasal spray for major depressive disorder with acute suicidal ideation or behavior: description of treatment access, utilization, and claims-based outcomes in the United States. Journal of Medical Economics. doi:10.1080/13696998.2023.2208993 ✓esketamine-coveragespravato-accessclaims-based-utilizationinterventional-access
- 4.Substance Abuse and Mental Health Services Administration (SAMHSA) (2025). FindTreatment.gov. Substance Abuse and Mental Health Services Administration. link ✓treatment-locatorfind-low-cost-caresliding-fee-clinicsfree-confidential-referral
4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy